What is the best TV mount for you? There are many reasons why you might want a TV mount: to clear up space from the floor and your shelving units, or just a better viewing position from your sofa.

The firm increased its portfolio allocation in CGEM by 87.70% over the last quarter. Deerfield Management Company, L.p. holds 3,280K shares representing 5.66% ownership of the company. In its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fortunately, a huge amount of this work is already underway. In this new newsletter series, The Climate Fix, we’ll be highlighting solutions that have the potential to make a difference at scale.

The General Confederation of Moroccan Enterprises (CGEM) has presented its key proposals for the 2025 Finance Law, aimed at fostering sustainable economic growth and job creation.

Your support makes all the difference. Scientists may finally have an explanation for why Mount Everest is so much taller than the other great Himalayan peaks – and still growing. Everest is ...

Commissions do not affect our editors' opinions or evaluations. If you’re looking for a fixed annuity, some products pay much higher guaranteed annuity rates and offer more benefits than others.

Fixed indexed annuities tie their performance to a stock market index. They offer principal protection and steady income in retirement. Fixed indexed annuities typically limit the returns you can ...

Amgen reports mixed results from Phase 3 trials, with rocatinlimab showing moderate success in atopic dermatitis and Uplizna outperforming expectations in myasthenia gravis, offering less frequent ...

A fixed annuity guarantees the investor a set return for the course of the annuity, typically starting at around three years. The annual interest rate compounds, and the entire amount is harvested ...

Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today received Human Research ...